Evidence map›Paper›PMID 40756900›Full record

ArticleBiomedical reports2025

Real-world effectiveness and safety of cefiderocol in critically ill patients with MDR Gram-negative infections: Results from a retrospective study.

Andrea Marino, Emmanuele Venanzi Rullo, Ylenia Russotto, Marco Visicaro, Cristina Micali, Mariagiovanna Coco, Antonio Edoardo Campanella, Giovanni Francesco Pellicanò, Carmelo Iacobello, Giuseppe Nunnari

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrea MarinoDepartment of Clinical and Experimental Medicine, University of Catania, I-95123 Catania, Italy.
Emmanuele Venanzi RulloUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, I-98122 Messina, Italy.
Ylenia RussottoUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, I-98122 Messina, Italy.
Marco VisicaroUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, I-98122 Messina, Italy.
Cristina MicaliUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, I-98122 Messina, Italy.
Mariagiovanna CocoDepartment of Clinical and Experimental Medicine, University of Catania, I-95123 Catania, Italy.
Antonio Edoardo CampanellaDepartment of Clinical and Experimental Medicine, University of Catania, I-95123 Catania, Italy.
Giovanni Francesco PellicanòUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, I-98122 Messina, Italy.
Carmelo IacobelloUnit of Infectious Diseases, 'Cannizzaro' Hospital for Emergencies, I-95126 Catania, Italy.
Giuseppe NunnariDepartment of Clinical and Experimental Medicine, University of Catania, I-95123 Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of multidrug-resistant (MDR) Gram-negative bacteria, particularly

Indexed as

Acinetobacter baumanniiantimicrobial stewardshipcefiderocolmultidrug-resistant bacterianovel cephalosporinsiderophore

Identifiers

PMID40756900
PMCPMC12312293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.